A detailed history of Worldquant Millennium Advisors LLC transactions in Repligen Corp stock. As of the latest transaction made, Worldquant Millennium Advisors LLC holds 50,276 shares of RGEN stock, worth $7.26 Million. This represents 0.06% of its overall portfolio holdings.

Number of Shares
50,276
Previous 44,939 11.88%
Holding current value
$7.26 Million
Previous $5.67 Million 32.07%
% of portfolio
0.06%
Previous 0.05%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$119.79 - $167.35 $639,319 - $893,146
5,337 Added 11.88%
50,276 $7.48 Million
Q2 2024

Aug 14, 2024

BUY
$120.0 - $182.95 $5.39 Million - $8.22 Million
44,939 New
44,939 $5.67 Million

Others Institutions Holding RGEN

About REPLIGEN CORP


  • Ticker RGEN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Instruments & Supplies
  • Shares Outstandng 55,491,200
  • Market Cap $8.02B
  • Description
  • Repligen Corporation develops and commercializes bioprocessing technologies and systems for use in biological drug manufacturing process in North America, Europe, the Asia Pacific, and internationally. It offers Protein A ligands that are the binding components of Protein A affinity chromatography resins; and cell culture growth factor products....
More about RGEN
Track This Portfolio

Track Worldquant Millennium Advisors LLC Portfolio

Follow Worldquant Millennium Advisors LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Worldquant Millennium Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Worldquant Millennium Advisors LLC with notifications on news.